Literature DB >> 30528987

Predicted heart mass is the optimal metric for size match in heart transplantation.

Evan P Kransdorf1, Michelle M Kittleson2, Lillian R Benck2, Jignesh K Patel2, Joshua S Chung3, Fardad Esmailian3, Brenda L Kearney2, David H Chang2, Danny Ramzy3, Lawrence S C Czer2, Jon A Kobashigawa2.   

Abstract

BACKGROUND: Donor-recipient size match is traditionally assessed by body weight. We assessed the ability of 5 size match metrics-predicted heart mass (PHM), weight, height, body mass index (BMI) and body surface area (BSA)-to predict 1-year mortality after heart transplant and to assess the effect of size match on donor heart turn down for size.
METHODS: The study cohort comprised 19,168 adult heart transplant recipients in the United Network for Organ Sharing registry between 2007 and 2016. Each size match metric was divided into 7 equally sized groups using the donor-recipient ratio for each metric. Single and multivariable Cox proportional hazard models for mortality 1 year after transplant were constructed.
RESULTS: Recipients in the severely (donor-recipient PHM ratio 0.54-0.86) undersized group for PHM experienced increased mortality, with a hazard ratio of 1.34 (95% confidence interval, 1.13-1.59; p < 0.001). There was no increased risk of death at 1 year if donors were undersized for weight, height, BMI, or BSA. We found that 32% of heart offers turned down for donor size would be acceptable using a PHM threshold of 0.86 or greater and that 14% of offers accepted (most of which are female donor to male recipient) were below this threshold.
CONCLUSIONS: PHM is the optimal donor-recipient size match metric for prediction of mortality after heart transplant. Many offers turned down for donor size were above the threshold for adequacy of size match by PHM identified, and thus, the use of PHM could improve donor heart utilization and post-transplant survival.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  donor-recipient size match; heart size; heart transplant; predicted heart mass; survival

Mesh:

Year:  2018        PMID: 30528987     DOI: 10.1016/j.healun.2018.09.017

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  22 in total

Review 1.  Heart Transplant Donor Selection Guidelines: Review and Recommendations.

Authors:  Shyama Sathianathan; Geetha Bhat
Journal:  Curr Cardiol Rep       Date:  2022-02-18       Impact factor: 2.931

2.  Oversized donor heart transplantation-clinical experience with an underestimated problem.

Authors:  Srikanth Kasturi; Thiruthani Kumaran; Varun Shetty; Julius Punnen; Shashiraj Subramanya; Bagirath Raghuraman; Venkat Rao Parachuri; Devi Prasad Shetty
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-05-26

Review 3.  Disparities in heart and lung transplantation.

Authors:  Wayne Tsuang; Rola Khedraki; Eileen Hsich
Journal:  Curr Opin Organ Transplant       Date:  2021-10-01       Impact factor: 2.269

4.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match.

Authors:  Kiran K Khush; Wida S Cherikh; Daniel C Chambers; Michael O Harhay; Don Hayes; Eileen Hsich; Bruno Meiser; Luciano Potena; Amanda Robinson; Joseph W Rossano; Aparna Sadavarte; Tajinder P Singh; Andreas Zuckermann; Josef Stehlik
Journal:  J Heart Lung Transplant       Date:  2019-08-10       Impact factor: 10.247

5.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric heart transplantation report - 2019; Focus theme: Donor and recipient size match.

Authors:  Joseph W Rossano; Tajinder P Singh; Wida S Cherikh; Daniel C Chambers; Michael O Harhay; Don Hayes; Eileen Hsich; Kiran K Khush; Bruno Meiser; Luciano Potena; Alice E Toll; Aparna Sadavarte; Andreas Zuckermann; Josef Stehlik
Journal:  J Heart Lung Transplant       Date:  2019-08-10       Impact factor: 10.247

6.  Discontinuing amiodarone treatment prior to heart transplantation lowers incidence of severe primary graft dysfunction.

Authors:  Benjamin Hoemann; Hiroo Takayama; Douglas L Jennings; Jiho Han; Masahiko Ando; Susan Restaino; Paolo Colombo; Maryjane Farr; Yoshifumi Naka; Koji Takeda
Journal:  Clin Transplant       Date:  2020-01-29       Impact factor: 2.863

7.  Increasing heart transplant donor pool by liberalization of size matching.

Authors:  Luise Holzhauser; Teruhiko Imamura; Nikhil Bassi; Takeo Fujino; Daisuke Nitta; Anthony J Kanelidis; Nikhil Narang; Gene Kim; Jayant Raikhelkar; Catherine Murks; David Onsager; Tae Song; Takeyoshi Ota; Valluvan Jeevanandam; Gabriel Sayer; Nir Uriel
Journal:  J Heart Lung Transplant       Date:  2019-08-24       Impact factor: 10.247

8.  Emerging Topics in Heart Failure: Contemporaneous Management of Advanced Heart Failure.

Authors:  Fabiana G Marcondes-Braga; Jefferson L Vieira; João David de Souza Neto; Gustavo Calado; Silvia Moreira Ayub-Ferreira; Fernando Bacal; Nadine Clausell
Journal:  Arq Bras Cardiol       Date:  2020-12       Impact factor: 2.000

9.  Influence of Gender in Advanced Heart Failure Therapies and Outcome Following Transplantation.

Authors:  María Dolores García-Cosío; Francisco González-Vilchez; Raquel López-Vilella; Eduardo Barge-Caballero; Manuel Gómez Bueno; Manuel Martínez-Selles; Jose María Arizón; Diego Rangel Sousa; José González-Costello; Sonia Mirabet; Félix Pérez-Villa; Beatriz Díaz Molina; Gregorio Rábago; Ana Portolés Ocampo; Luis de la Fuente Galán; Iris Garrido; Juan F Delgado
Journal:  Front Cardiovasc Med       Date:  2021-02-25

10.  Reducing the wait: TCV can expand the donor pool for heart transplant candidates.

Authors:  Nicholas A Szugye; Ryan A Moore; Alia Dani; Angela Lorts; Farhan Zafar; David L S Morales
Journal:  Pediatr Transplant       Date:  2021-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.